ARTICLE | Company News
2-BBB Medicines, TTY Biopharm deal
April 14, 2017 7:44 PM UTC
The companies formed a joint venture in Taiwan to develop and commercialize 2-BBB’s multiple sclerosis candidate 2B3-201. 2-BBB will grant the JV exclusive rights to 2B3-201 and will receive a 33.3% s...